Get startedLog in
    Picture of ExpreS2ion Biotech Holding AB logo

    EXPRS2 — ExpreS2ion Biotech Holding AB News Story

    0.000.00%
    se flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro CapSucker Stock
    All News

    Brief: Expres2ion, Serum Institute Of India Enter In Term Sheet Regarding Novel Malaria Vaccines

    Picture of ExpreS2ion Biotech Holding AB logoExpreS2ion Biotech Holding AB
    16/10/2024 12:53
    Oct 16 (Reuters) - ExpreS2ion Biotech Holding AB
 EXPRS2.ST :
    * EXPRES2ION AND SERUM INSTITUTE OF INDIA HAVE ENTERED IN A
TERM
SHEET REGARDING PROPOSED DEVELOPMENT AND COMMERCIALISATION OF
NOVEL MALARIA VACCINES
    * WILL RECEIVE LIMITED MILESTONE PAYMENTS, LOWER
SINGLE-DIGIT
PERCENTAGE ROYALTIES BASED ON FUTURE NET SALES

Source text for Eikon:  ID:nWkrjjzdz 
Further company coverage:  EXPRS2.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

    Recent news on ExpreS2ion Biotech Holding AB

    See all news